Launch of Reinnervate Perfusion System for 3D cell culture
Reinnervate today announced the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media.
This product allows scientists to create cell based models that are another step closer to the environment experienced by cells and tissue in vivo. The systems can also be used to create complex co-cultures, multi-organ systems and to study paracrine effects.
The Alvetex perfusion system is compatible with the following methods:
3D cell culture using Alvetex well insert technology
3D co-culture using
Standard 2D cell culture
Hydrogel-based 3D cell cultures
Transwell and well insert technology from various suppliers
Note:Reinnervate Ltd (County Durham, England) was acquired by REPROCELL Inc (Yokohama, Japan) in August 2014. Biopta Ltd (Glasgow, Scotland) was acquired by REPROCELL in November 2015. REPROCELL Europe Ltd was established by merging Reinnervate and Biopta in June 2016.